IGI Logo

Shukra Pharmaceuticals is locked its upper circuit at Rs. 19.96, up by 0.39 points or 1.99% from its previous closing of Rs. 19.57 on the BSE.

The scrip opened at Rs. 19.96 and has touched a high and low of Rs. 19.96 and Rs. 19.96 respectively. So far 64621 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 1 has touched a 52 week high of Rs. 27.15 on 05-Mar-2025 and a 52 week low of Rs. 5.75 on 21-Nov-2024.

Last one week high and low of the scrip stood at Rs. 19.96 and Rs. 17.37 respectively. The current market cap of the company is Rs. 874.01 crore.

The promoters holding in the company stood at 50.96%, while Institutions and Non-Institutions held 0.11% and 48.93% respectively.

Shukra Pharmaceuticals has inaugurated four new branch offices- one in Mumbai, the financial capital of India, another in Gurgaon, a rapidly growing business and healthcare hub in the National Capital Region (NCR), another in Bangalore and another in Kolkata. This expansion marks a pivotal step in its journey toward wider market engagement and operational reach. 

The newly established branches will act as pivotal centers for: Exploring and serving high-potential markets; Actively participating in tenders issued by Government, Semi-Government, and Private sector institutions; and Building closer partnerships with institutional clients, procurement agencies, and healthcare stakeholders. Its Mumbai, Gurgaon (NCR), Bangalore and Kolkata branches are expected to catalyze for enhanced business development and market penetration, aligned with its mission of delivering quality pharmaceutical solutions across India.

Shukra Pharmaceuticals is an ambitious organisation with a deep-rooted focus on sustainability with its impressive range of solutions.